Join to View Full Profile
240 W Thomas Rd# 301Phoenix, AZ 85013
Phone+1 602-406-6262
Fax+1 602-406-6261
Dr. Criswell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Susan Criswell is a highly experienced Neurologist based in Phoenix, AZ with a subspecialty in Movement Disorder. She is currently a Professor at the Barrow Neurological Institute and has a considerably rich academic background which includes hold previous positions at the Washington University in Saint Louis. She completed her Neurology residency at the Washington University/B-JH/SLCH Consortium and graduated from the University of Nebraska College of Medicine in 2001. Her area of expertise includes managing movement disorders, Parkinson's disease, and administering botulinum toxin injections for movement disorders. Dr. Criswell has also made significant contributions to her field through publications on environmental and clinical risk factors for Parkinson's disease and neurodegenerative conditions.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2001 - 2005
University of Nebraska College of MedicineClass of 2001
Certifications & Licensure
AZ State Medical License 2022 - 2027
MO State Medical License 2005 - 2023
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification RxNT EHR, Networking Technology dba RxNT, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2014, 2016-2017
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
- Flexible-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2020 Jan 06
Roles: Contact
Publications & Presentations
PubMed
- Biomarkers.Elijah Mak, Scott A Przybelski, Robert I Reid, Angela J Fought, Christopher G Schwarz
Alzheimer's & Dementia. 2025-12-01 - Cholinergic dysfunction in occupational manganese exposure.T Noah Hutson, Susan Searles Nielsen, Natalie Senini, John O'Donnell, Hubert P Flores
Neurotoxicology. 2025-12-01 - Utilizing T1-weighted MRI intensity indices to evaluate in-vivo neurotoxicity in a South African cohort with environmental manganese exposure.Susan R Criswell, Irene Faust, Susan Searles Nielsen, Wendy W Dlamini, Gill Nelson
Journal of Trace Elements in Medicine and Biology. 2025-10-01
Press Mentions
$3.7 Million Aimed at Studying Effect of Manganese Exposure on Cognitive SkillsJune 4th, 2020- List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
